NEWS
chevron

NEWS

Patients can benefit from whole genome sequencing for immunotherapy

Immunotherapy is an effective treatment for many people with cancer. The number of abnormalities in the DNA of the tumor in many cases predicts the likelihood of success of immunotherapy. This is currently usually investigated with gene panel tests, whereby the accuracy of the results is vitally important. Joanne Mankor and her fellow researchers compared […]

1 October 2020

NEWS

Whole Genome Sequencing feasible in clinical practice

Interim WIDE analysis gives researchers more confidence in a positive outcome. On 21 September 2020, Dr. Kim Monkhorst, who is a pathologist at the Netherlands Cancer Institute, presented the interim results of the WIDE study at ESMO 2020. Dr. Monkhorst is principal researcher in the WIDE study together with Prof. Gerrit Meijer. With these results […]

20 September 2020

NEWS

SAGE: New algorithm for analysis of tumor DNA reveals mutations previously not found

At Hartwig we “analyse sequenced tumor DNA”. This is something we try to continuously improve. These analyses are shared with hospitals to help them find the best treatment for the patient. In addition, we aggregate all these analyses into our database from which we service researchers so that they can improve care for tomorrow’s patients.  […]

23 July 2020

RECENTE TWEETS
chevron